Exploring α-ET. To explore a different substance…

Names:
α-ET
AET
Monase
3-(2-Aminobutyl)indole
Tryptamine, α-ethyl
Indole, 3-(2-aminobutyl)
α-Ethyltryptamine
IUPAC name:
1-(1H-Indol-3-yl)butan-2-amine
5011 · C12H16N2 · 188.269
InChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3
ZXUMUPVQYAFTLF-UHFFFAOYSA-N This stereoisomer Any stereoisomer

Meyers-Riggs, B. Alpha substituted tryptamines. countyourculture, countyourculture: rational exploration of the underground, 1 Mar 2012.

Glennon, RA; Young, R; Jacyno, JM. Indolealkylamine and phenalkylamine hallucinogens: Effect of α-methyl and N-methyl substituents on behavioral activity. Biochem. Pharmacol., 1 Apr 1983, 32 (7), 1267–1273. 591 kB. https://doi.org/10.1016/0006-2952(83)90281-2

Krebs, KM; Geyer, MA. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats. Psychopharmacology, 1 Dec 1993, 113 (2), 284–287. 472 kB. https://doi.org/10.1007/BF02245712

Glennon, RA; Gessner, PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. 731 kB. https://doi.org/10.1021/jm00190a014

Huang, X; Johnson, MP; Nichols, DE. Reduction in brain serotonin markers by α-ethyltryptamine (Monase). Eur. J. Pharmacol., 1 Jan 1991, 200 (1), 187–190. 420 kB. https://doi.org/10.1016/0014-2999(91)90686-K

Glennon, RA. MDMA-like stimulus effects of α-ethyltryptamine and the α-ethyl homolog of DOM. Pharmacol. Biochem. Behav., 1 Oct 1993, 46 (2), 459–462. 396 kB. https://doi.org/10.1016/0091-3057(93)90379-8

Kalir, A; Szara, S. Synthesis and pharmacological activity of alkylated tryptamines. J. Med. Chem., 1 May 1966, 9 (3), 341–344. 482 kB. https://doi.org/10.1021/jm00321a017

Hong, S; Young, R; Glennon, RA. Discriminative stimulus properties of α-ethyltryptamine optical isomers. Pharmacol. Biochem. Behav., 1 Oct 2001, 70 (2–3). 131 kB. https://doi.org/10.1016/S0091-3057(01)00605-0

Schulze-Alexandru, M; Kovar, K; Vedani, A. Quasi-atomistic receptor surrogates for the 5-HT2A receptor: A 3D-QSAR study on hallucinogenic substances. Quant. Struct.-Act. Relat., 1 Dec 1999, 18 (6), 548–560. 312 kB. https://doi.org/10.1002/(SICI)1521-3838(199912)18:6<548::AID-QSAR548>3.0.CO;2-B

Daldrup, T; Heller, C; Matthiesen, U; Honus, S; Bresges, A; Haarhoff, K. Etryptamin, eine neue designer-droge mit fataler Wirkung. Z. Rechtsmed., 1 Sep 1986, 97 (1), 61–68. 496 kB. https://doi.org/10.1007/BF00200960

Steiner, WG; Pscheidt, GR; Costa, E; Himwich, HE. α-Ethyltryptamine (etryptamine): An electroencephalographic, behavioral and neurochemical analysis. Psychopharmacology, 1 Sep 1963, 4 (5), 354–366. 780 kB. https://doi.org/10.1007/BF00405246

Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens. Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #57

Nichols, DE. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr. Transp. Signal, 1 Sep 2012, 1 (5), 559-579. 573 kB. https://doi.org/10.1002/wmts.42

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Shulgin, AT. Hallucinogens. In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., Wiley & Co., 1981; pp 1109–1137. 4.7 MB. #30

Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1976; Vol. 4, pp 59–146. 3.1 MB. #XXIV,XXVII

DMT
2,α-DMT
α,N-DMT
NET
1,α-DMT
α,α-DMT
4-Me-α-MT
7-Me-AMT
N-Methylhomotryptamine
5-Ethyltryptamine
2787
Fenproporex
5786
CMMA
5-Me-AMT
isoDMT
21 August 2018 · Creative Commons BY-NC-SA ·